NVNO — enVVeno Medical Balance Sheet
0.000.00%
Annual balance sheet for enVVeno Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 54.7 | 39 | 46.4 | 43.2 | 28.2 |
| Prepaid Expenses | |||||
| Total Current Assets | 55 | 39.4 | 46.9 | 43.7 | 28.8 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.6 | 2.19 | 1.68 | 1.19 | 0.705 |
| Other Long Term Assets | |||||
| Total Assets | 57.7 | 41.7 | 48.6 | 45 | 29.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 1.58 | 1.53 | 1.37 | 2.1 | 2.12 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.29 | 2.93 | 2.44 | 2.79 | 2.43 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 54.4 | 38.7 | 46.2 | 42.2 | 27.1 |
| Total Liabilities & Shareholders' Equity | 57.7 | 41.7 | 48.6 | 45 | 29.6 |
| Total Common Shares Outstanding |